Using PCG-Arginine nanoparticle mediated intranasal delivery of dynorphin A (1-8) to improve neuroprotection in MCAO rats
Mengying Chen,Bo Lei,Min Wang,Hong Sun,Xiaodong Zhang,Jinming Shi,Jiaxin Fan,Qingling Yao,Shuang Du,Huiyang Qu,Yuxuan Cheng,Shuyin Ma,Meijuan Zhang,Shuqin Zhan
DOI: https://doi.org/10.1016/j.jddst.2021.103059
IF: 5
2022-01-01
Journal of Drug Delivery Science and Technology
Abstract:In our previous research, the contents of dynorphin A(1-8) decreased gradually in ischemic cortices in rats after transient focal cerebral ischemia and an intracerebroventricular administration of synthetic dynorphin A(1-8) reduced the volume of cerebral infarction in mice. However, as a macromolecule neuropeptide, dynorphin A (1-8) is unlikely to cross the blood-brain barrier (BBB) by noninvasive oral or intravenous administration and is easily inactivated in blood. In this study, we developed Dynorphin A(1-8)-loaded PCG-Arginine (DYN-PCGA) nanoparticles. The novel nanoparticles had small particle size (253.27 +/- 70.08 nm), high stability (zeta potential-6.2 +/- 0.6 mV and PDI of 0.466 +/- 0.023), and strong encapsulation efficiency (33.80 +/- 1.13%) and load capacity (5.63 +/- 0.19%). PC-12 cells were used to evaluate the growth enhancement and cytotoxicity of DYN-PCGA in vitro. Middle cerebral artery occlusion (MCAO) rats were used to assess the therapeutic effects of DYN-PCGA in vivo. We found that PC-12 cells under DYN-PCGA treatment showed better cell viability at low concentrations; even at high concentrations, no cytotoxicity was found. MCAO rats under intranasal administration of DYNPCGA showed better behavioral improvement, higher extent of Bcl-2, activity of SOD along with much lower level of infarction volume, brain water content, number of cell apoptosis, extent of Bax and Caspase-3, and concentration of MDA compared with those under intranasal administration of DYN solution and intravenous administration of DYN-PCGA. In summary, dynorphin A(1-8), with advantages of nanoparticles and intranasal administration, could be effectively delivered to central nervous system (CNS). DYN-PCGA inhibited oxidative stress and apoptosis against cerebral ischemia/reperfusion injury, improving neuroprotection in MCAO rats.